'My kid got sunburned because of mislabeled sunscreen' Jumping on a report that found many sunscreens overstate their protection factors, a Brooklyn, New York, parent has filed a class-action lawsuit against the makers of Banana Boat Sunscreen, saying he bought a bottle of kids lotion that was supposed to be SPF 50 but turned out to only have an SPF of 12.
Dad tattoos scar on head to honor son battling brain cancer A father of an 8-year-old boy battling brain cancer had a scar tattooed on his head after the boy said his own scars made him feel like a “monster.”
Cancer drug prices highest in US, least affordable in India, China-study Americans pay the highest prices in the world for cancer drugs, but the treatments are least affordable in lower income countries, according to the results of a new study released on Monday.
Regulators approve first gene-editing test in humans to aid cancer research Federal regulators have approved the first gene-editing test in humans, and if it receives full approval, scientists would use the technology to edit immune cells to fight some types of cancers.
Breast cancer researchers may have found the 'holy grail' A new study could bring hope to thousands of women who are susceptible to breast and ovarian cancer, the Telegraph reports.
Ken Griffey Sr., Jr., take a crack at prostate cancer MLB’s famous father-son duo Ken Griffey Sr. and Jr. have long-been household names due to their remarkable careers on the baseball field.
Doctors blame many factors for futile care, themselves included Doctors who were asked about causes of inappropriate care at the end of life didn't have to look far to place blame.
Nurse who beat childhood leukemia twice now works at hospital where she was treated A college graduate in Georgia who survived childhood cancer twice has returned to the hospital where doctors saved her life— this time, not to undergo treatment, but to help others through similar plights that she endured as a little girl.
UK cost agency speeds approval of Bristol melanoma drug cocktail British melanoma patients will be the first in Europe to receive a new drug cocktail combining two immunotherapy treatments, following an unusually rapid approval by the country's healthcare cost agency NICE on Friday.
